title: Polymorphism at position -308 of the tumour necrosis factor alpha gene and rheumatoid arthritis pharmacogenetics.
authors.forename: J E
authors.initials: JE
authors.lastname: Fonseca
authors.forename: T
authors.initials: T
authors.lastname: Carvalho
authors.forename: M
authors.initials: M
authors.lastname: Cruz
authors.forename: P
authors.initials: P
authors.lastname: Nero
authors.forename: M
authors.initials: M
authors.lastname: Sobral
authors.forename: A F
authors.initials: AF
authors.lastname: Mourão
authors.forename: J
authors.initials: J
authors.lastname: Cavaleiro
authors.forename: D
authors.initials: D
authors.lastname: Ligeiro
authors.forename: I
authors.initials: I
authors.lastname: Abreu
authors.forename: M
authors.initials: M
authors.lastname: Carmo-Fonseca
authors.forename: J C
authors.initials: JC
authors.lastname: Branco
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000235:genetics*; D004351:Drug Resistance / Q000235:genetics; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D011110:Polymorphism, Genetic; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab